The Daily Breakdown: February 21, 2025

by | Feb 22, 2025

Momentum Movers

  • $HIMS down 25% after the company announced it acquired a US-based peptide facility. Additionally, the FDA stated that the semaglutide injection shortage is resolved as of February 21.
  • $UNH down 7% on a report that the DOJ is investigating the company over Medicare billing practices. 
  • $TSLA down 4% amid general technology sector weakness.     
  • $MELI up 7% after the company reported better-than-expected financial results.
  • $CELH up 27% after the company reported better-than-expected Q4 financial results.
  • $PONY up 32% after the company announced the launch of paid robotaxi services from multiple locations in Guangzhou’s city center to key transportation hubs. 
  • $GEV down 8% amid general market weakness on US consumer and economic concerns. 
  • $APP down 7% on continued momentum lower after a short report was issued against the company recently. 
  • $AKAM down 21% after reporting financial results and receiving price target cuts. 
  • $NVDA down 4% after DeepSeek unveiled its new model. 

Sector Performance 

Market News

  • The SEC is reportedly dismissing an enforcement case against $COIN.
  • The Trump administration is reportedly exploring a bold financial system overhaul.

Upcoming Events 2/24/25 

  • Chicago Fed National Activity
  • Dallas Fed Manufacturing Business Index
  • 2-Year Note Auction
  • Earnings: $DPZ, $HIMS, $BRK.B, $RIOT, $AZUL, $TEM, $BCRX, $CLF, $KSPI, $ZM, $LINC, $FANG, $SMMT, $CHGG, $TCOM

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *